Resultats de la cerca - Stephan A. Grupp

Refinar resultats
  1. 1
    Stem cell transplantation for neuroblastoma

    Stem cell transplantation for neuroblastoma per Jonathan D. Fish, Stephan A. Grupp

    Publicat 2007
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation.

    Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation. per Stephan A. Grupp, Judith A.K. Harmony

    Publicat 1985
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Toxicity management for patients receiving novel T-cell engaging therapies

    Toxicity management for patients receiving novel T-cell engaging therapies per David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)

    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) per David T. Teachey, Alix E. Seif, Stephan A. Grupp

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies per David T. Teachey, Stephan A. Grupp, Valerie I. Brown

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street

    Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street per David M. Barrett, Stephan A. Grupp, Carl H. June

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors

    Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors per David M. Barrett, Jonathan D. Fish, Stephan A. Grupp

    Publicat 2010
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Chimeric antigen receptor T-cell therapy for ALL

    Chimeric antigen receptor T-cell therapy for ALL per Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies per David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia per Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies per Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy

    RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy per Christina Coughlin, Barbara A. Vance, Stephan A. Grupp, Robert H. Vonderheide

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Antibody-modified T cells: CARs take the front seat for hematologic malignancies

    Antibody-modified T cells: CARs take the front seat for hematologic malignancies per Marcela V. Maus, Stephan A. Grupp, David Porter, Carl H. June

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' per David T. Teachey, Michael R. Bishop, David G. Maloney, Stephan A. Grupp

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers

    Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers per Rajat K. Das, Lauren Vernau, Stephan A. Grupp, David M. Barrett

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Lingering effects of chemotherapy on mature T cells impair proliferation

    Lingering effects of chemotherapy on mature T cells impair proliferation per Rajat Das, Roddy S. O’Connor, Stephan A. Grupp, David M. Barrett

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study

    Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study per Alix E. Seif, Catherine S. Manno, Cecilia Sheen, Stephan A. Grupp, David T. Teachey

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

    ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges per Stéphane Depil, Philippe Duchâteau, Stephan A. Grupp, G J Mufti, Laurent Poirot

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-alpha and Ig-beta/gamma.

    Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-alpha and Ig-beta/gamma. per Stephan A. Grupp, Kerry S. Campbell, Richard Mitchell, John C. Cambier, Abul K. Abbas

    Publicat 1993
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Chimeric Antigen Receptor Therapy for Cancer

    Chimeric Antigen Receptor Therapy for Cancer per David M. Barrett, Nathan Singh, David L. Porter, Stephan A. Grupp, Carl H. June

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: